Teva Pharma Ind Shs Sponsored American Deposit Receipt Repr 1 Sh $52.37

up +0.27


29/8/2014 11:49 AM  |  NYSE : TEVA  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get TEVA Trend Analysis - it has outperformed the S&P 500 by 14%

Partner Headlines

  1. 4 Biotechs That Might Be Bought Soon

    IBD
  2. Notable Hedge Funds Disclose Additions And Reductions To Holdings

    Benzinga
  3. Jana Partners LLC Files its 13F

    Benzinga
  4. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  5. Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats

    IBD
  6. Did George Soros Sell His Stake In Israeli Based SodaStream Due To Political ...

    Benzinga
  7. 5 Drug Companies Profiting From Generics

    Benzinga
  8. Top 5 Earnings Reports To Watch After The Close Tue.

    IBD
  9. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD
  10. George Soros Reveals His Largest Stake

    GuruFocus
  11. Sofinnova Ventures Closes $500M Fund

    FoxBusiness
  12. Israel's Market Appears Unfazed By Rising Conflict

    IBD
  13. George Soros Keeps Buying TEVA, EQT, YPF, EGN, CZR And Keeps Selling GOOGL, ...

    GuruFocus
  14. UPDATE: Teva Announces FDA Acceptance of NDA For Inhaler

    Benzinga
  15. 4 Top Performing Health Care Stocks With More Potential Upside

    Benzinga
  16. Salix, Akorn, Regeneron Lead Drug Stock Rally

    IBD
  17. Top 4 Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  18. Diamond Hill Capital Comments on Teva Pharmaceutical Industries Ltd

    GuruFocus
  19. Diamond Hill Select Fund Commentary - First Quarter 2014

    GuruFocus
  20. Teva Pharmaceutical

    IBD
  21. Generic-Drug Makers Climb Ranks; Several In Buy Range

    IBD
  22. Teva Turmoil: Shares Up, Board Trimmed, CEO To Retire

    Benzinga
  23. Wells Fargo Initiates Coverage On The Pharmaceutical Space

    Benzinga
  24. Top Guru Held Asian Companies of the First Quarter

    GuruFocus
  25. Teva to buy Labrys Biologics

    IBD
  26. Chicago sues painkiller firms

    IBD
  27. Benzinga's M&A Chatter for Tuesday June 3, 2014

    Benzinga
  28. Teva Acquiring Labrys Biologics For Migraine Drug

    IBD
  29. Richard Snow's Top Five Highlight Finance and Healthcare Sectors

    GuruFocus
  30. Benzinga's M&A Chatter for Wednesday May 7, 2014

    Benzinga
  31. ETF Outlook For Tuesday May 6, 2014 (EUFN, ITA, EIS, UAE)

    Benzinga
  32. Wrong Marketing Lesson by Big Pharma

    GuruFocus
  33. Sterne Agee Sees Mixed Factors For Teva Pharmaceutical Industries Ltd.

    Benzinga
  34. Teva EPS tops; rivals seen?

    IBD
  35. Market Wrap For May 1: Markets Mixed To Start The New Month

    Benzinga
  36. Earnings Scheduled For May 1, 2014

    Benzinga
  37. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
  38. Actavis Reporting Q1 Earnings Amid Merger Frenzy

    IBD
  39. US Stock Futures Up Ahead Of Earnings, Consumer Confidence Data

    Benzinga
  40. Morning Market Losers

    Benzinga
  41. Benzinga's Top #PreMarket Losers

    Benzinga
  42. UPDATE: Teva, Oncogenex Offer Top-Line Survival Results of Phase III SYNERGY ...

    Benzinga
  43. Nasdaq Could Be in for a Bounce

    FoxBusiness
  44. Actavis got a Pfizer

    IBD
  45. Teva Settles Patent Litigation with Pfizer on Celebrex; Has Received Tenative ...

    Benzinga
  46. Sterne Agee Sees Teva Pharmaceutical Outperformance Continuing

    Benzinga
  47. Teva Unveils Generic Lunesta Tablets in US

    Benzinga
  48. Teva Announces First Approval and Launch of Generic Lovaza® Capsules in ...

    Benzinga
  49. Market Wrap For April 7: Bears In Complete Control As Markets Get Hammered ...

    Benzinga
  50. Citigroup Slaps $70 Price Target on Teva, Highest on Street

    Benzinga
Trading Center